Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography–mass spectrometry
- 11 April 2003
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 788 (2) , 339-350
- https://doi.org/10.1016/s1570-0232(03)00039-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patientsAIDS, 2001
- High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral ActivitiesAntimicrobial Agents and Chemotherapy, 2001
- Simple and rapid determination of nevirapine in human serum by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Transport, metabolism and elimination mechanisms of anti-HIV agentsAdvanced Drug Delivery Reviews, 1999
- Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1997